Interline Therapeutics, Inc. — Form D
Interline Therapeutics, Inc. of South San Francisco, CA, a company, filed a Form D exempt-offering notice with the SEC on 2021-11-16. The offering totals $50.0M, of which $50.0M was reported sold. Industry: Other Health Care.
Offering
- Filed: 2021-11-16
- Form: D
- Accession: 0001567619-21-020559
- Industry: Other Health Care
- Exemptions: 06b
- Total offering: $50.0M
- Amount sold: $50.0M
- Investors: 5
- Date of first sale: 2021-11-08
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-421327
Issuer
- Name: Interline Therapeutics, Inc.
- CIK: 0001844239
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2021
- Address: 290 Utah Ave., Ste. 300, South San Francisco, CA, 94080
- Phone: 415-787-6009
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Vikam Bajaj | Director | South San Francisco, CA |
| Jay Parrish | Director | South San Francisco, CA |
| Zachary Sweeney | Director | South San Francisco, CA |
| James Tananbaum | Director | South San Francisco, CA |
| Michael Varney | Director | Watertown, MA |
| Zachary Sweeney | Executive Officer | South San Francisco, CA |
| Vikram Bajaj | Director | Wobutn, MA |
Other filings by this issuer (2)
More